Case Studies


Government and industry cancer researchers using interoperable digital identities, digital signatures and cloud computing were able to accelerate initiation of a clinical trial while lowering its costs. The ongoing study involves researchers at the National Cancer Institute, Bristol-Myers Squibb, and Sanofi. Click for white paper


AstraZeneca
AstraZeneca
has been submitting its required drug-reporting documents electronically to the U.S. Food and Drug Administration since mid-2006 using the SAFE-BioPharmaTM digital signature standard. - Summary (pdf) | pdf Full Story (pdf)


pfizer
"Pfizer's Implementation of SAFE-BioPharma® Digital Signatures for Electronic Lab Notebooks,” is a 19-page white paper describing how the company successfully introduced to its Global Research and Development organization electronic notebooks signed with SAFE-BioPharma digital signatures. Pfizer’s digitally signed Chemistry electronic Notebooks (CeN) have more than 2200 users within Pfizer and average more than 1000 signatures per day. -Summary (pdf) | pdf Full Story (pdf)